Monitor for any future amendment converting this 13G to a 13D, which would signal activist intent. For now, the passive filing is routine and unlikely to drive price action.
Price Chart
Executive Summary
Regal Partners Funds Management Pty Ltd disclosed a passive 3.34% beneficial ownership stake in Radiopharm Theranostics Ltd via Schedule 13G, holding 157,139,443 shares (including ordinary shares and ADSs). The filing certifies the stake was acquired in the ordinary course of business with no intent to influence control, making this a routine passive disclosure.
Key Financial Metrics
Key Facts
- Regal Partners Funds Management Pty Ltd filed Schedule 13G disclosing beneficial ownership of 157,139,443 shares in Radiopharm Theranostics Ltd.
- The stake represents 3.34% of shares outstanding as of September 30, 2026.
- The filing certifies passive intent under Rule 13d-1(b) — no intent to change or influence control.
- The stake comprises 145,146,643 ordinary shares and 39,976 American Depositary Shares (each ADS represents 300 ordinary shares).
- Regal Partners Limited is also named as a joint filer, holding the same number of shares.
Financial Impact
3.34% passive stake — no transaction price disclosed
Risk Factors
- Regal Partners could later convert to activist 13D status, though no indication of that in this filing.
- The 3.34% stake is below typical activist threshold, reducing near-term catalyst potential.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0001214659-26-012928 |
| Document: 0001214659-26-012928-index.html | 0001214659-26-012928 |
| Document: 0001214659-26-012928.txt | 0001214659-26-012928 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 6-K | — | awaiting T+5 | — | — |
Oct 20, 2026 6d ago | 6-K | $0.9900 | awaiting T+5 | — | $0.9600 (−3.03%) |
Oct 14, 2026 11d ago | SC 13G | $1.08 $0.9500 | ▼ −12.04% | ▼ −11.02% | $0.9600 (−11.11%) |
Oct 5, 2026 21d ago | 6-K | $1.27 $1.11 | ▼ −12.60% | ▼ −13.02% | $0.9600 (−24.41%) |
Oct 1, 2026 25d ago | 6-K | $1.48 $1.11 | ▼ −25.00% | ▼ −26.30% | $0.9600 (−35.14%) |
Sep 30, 2026 26d ago | 6-K | $1.62 $1.15 | ▼ −29.01% | ▼ −30.93% | $0.9600 (−40.74%) |
Sep 24, 2026 4w ago | EFFECT | $1.57 $1.48 | ▲ +5.85% | ▲ +5.43% | $0.9600 (+38.93%) |
Sep 22, 2026 4w ago | 6-K | $1.65 $1.52 | ▼ −7.88% | ▼ −6.69% | $0.9600 (−41.82%) |
Sep 14, 2026 6w ago | 6-K | $2.01 $1.61 | ▼ −19.90% | ▼ −20.01% | $0.9600 (−52.24%) |
Sep 11, 2026 6w ago | 6-K | $1.98 $1.65 | ▼ −16.67% | ▼ −16.45% | $0.9600 (−51.52%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers